Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center

International Journal of Clinical Pharmacy

Volumn 34, Issue 1, 2012, Pages 27-31

  Tuffaha, Haitham W ^a   Abdelhadi, Ola ^a   Al Omar, Suha ^a  

^a KING HUSSEIN CANCER CENTER   (Jordan)

Author keywords

Ambulatory; Clinical pharmacy; Jordan; Pediatric hematology oncology

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; LORATADINE; MERCAPTOPURINE; METHOTREXATE; ONDANSETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CENTER; CLINICAL PHARMACY; DRUG USE; HEALTH EDUCATION; HUMAN; JORDAN; OUTPATIENT CARE; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SAFETY; PHARMACIST; PRIORITY JOURNAL; AMBULATORY CARE; CHILD; HEALTH CARE QUALITY; HOSPITAL PHARMACY; METHODOLOGY; NEOPLASM; ORGANIZATION AND MANAGEMENT; PEDIATRICS; PROFESSIONAL STANDARD;

AMBULATORY CARE; ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; CHILD; CONTINUITY OF PATIENT CARE; HUMANS; JORDAN; NEOPLASMS; PATIENT EDUCATION AS TOPIC; PEDIATRICS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; QUALITY ASSURANCE, HEALTH CARE;

EID: 84860793711     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9600-4     Document Type: Article

References (9)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-43.
2. Katherine KK, Mark PO, Beverly LB. ASHP survey of ambulatory care pharmacy practice in health systems-2004. Am J Health-Syst Pharm. 2005;62:274-84.
3. Wong SW, Gray ES. Clinical pharmacy services in oncology clinics. J Oncol Pharm Pract. 1999;5(1):49-54.
4. Shah S, Dowell J, Greene S. Evaluation of clinical pharmacy services in a haematology/oncology outpatient setting. Ann Phar-macother. 2006;40(9):1527-33.
5. Ruder AD, Smith DL, Madsen MT, Kass FH. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? J Oncol Pharm Pract. 2011; doi:10.1177/10781 55210389216 [Epub ahead of print].
6. Valgus JM, Faso A, Gregory KM, Jarr S, Savage S, Caiola S, et al. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center. Am J Health Syst Pharm. 2011;68(7):613-9.
7. Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, Relling MV, Hoffman JM. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm. 2011;68(2):143-50.
8. Lam MS. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs. Pharmacotherapy. 2011;31(2):164-92.
9. Kondryn HJ, Edmondson CL, Hill J, Eden TO. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol. 2011;12(1):100-8.